3-aminobenzamide has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cardinale, A | 1 |
| Paldino, E | 1 |
| Giampà, C | 1 |
| Bernardi, G | 1 |
| Fusco, FR | 1 |
1 other study available for 3-aminobenzamide and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
PARP-1 Inhibition Is Neuroprotective in the R6/2 Mouse Model of Huntington's Disease.
Topics: Animals; Blotting, Western; Body Weight; Brain-Derived Neurotrophic Factor; Corpus Striatum; Cyclic | 2015 |